體外式薄膜型人工肺(ECMO)設備(心血管)-全球市場分析及預測模式(COVID-19對市場造成的影響)

本報告詳細探討體外膜氧合裝置用於治療心肌梗死，心力衰竭，心源性休克，先天性心臟病和急性呼吸窘迫綜合徵的方法。由於肺部，心臟或兩者的並發症，此類患者發展出無法適當地為其血液充氧的功能。

將靜脈插管插入頸靜脈或股靜脈，以從上/下腔靜脈排出靜脈血，並將含氧的血液返回至右心房。將動脈套管插入主動脈或股動脈以繞過心臟和肺部，並從ECMO機將含氧血液返回到動脈系統中。氧合器用於在返回心臟或動脈系統之前，通過去除CO2並給靜脈血氧合來代替肺部的作用。泵用於管理靜脈血的排出，通過充氧器的流量以及返回充氧血液的流量。

本報告提供體外式薄膜型人工肺(ECMO)設備市場相關調查，提供市場概要，以及2015∼2030年的市場預測，各市場區隔，各國的趨勢等資訊。

• 主要的產業趨勢洞察
• 2015年∼2030年各分類市場預測
• 手術數量，台數，平均銷售價格，各分類市場價值相關詳細資料

全球地區，各國趨勢

• 各國分析
• SWOT分析
• 競爭趨勢

健康護理系統概要

• 醫療保健制度的各國概要
• 各國給付方針
• 國家固有的醫療技術相關法規趨勢

網羅的企業:GetingeUSA Inc(MAQUET)，Terumo Corp，ALung Technologies，LivaNova plc(Sorin Group)，Medtronic plc，MicroPort Scientific Corporation，Eurosets Srl，OriGen Biomedical Inc，Fresenius Medical Care Group(Xenios AG)，其他

觀察對象國家:美國，英國，德國，法國，義大利，西班牙，巴西，中國，印度，俄羅斯，日本，澳洲，加拿大，墨西哥，韓國，丹麥，愛爾蘭，荷蘭，紐西蘭，南非，瑞典，瑞士，奧地利，比利時，芬蘭，以色列，挪威，波蘭葡萄牙，台灣，捷克，希臘，匈牙利，土耳其，埃及，沙烏地阿拉伯，阿拉伯聯合大公國，阿根廷，智利

Extracorporeal Membrane Oxygenation (ECMO) Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular therapeutic area.

The model discusses the use of Extracorporeal Membrane Oxygenation Devices are used to treat Myocardial Infraction, Heart Failure, Cardiogenic Shock, Congenital Heart Disease and Acute Respiratory Distress Syndrome. Such patients develop the inability to properly oxygenate their blood, due to complications of the lung, heart, or both.

Venous Cannulae are inserted into the jugular vein or the femoral vein to drain venous blood from the superior/inferior vena cava and returning oxygenated blood to the right atrium. Arterial cannulae are inserted into the aortic artery or the femoral artery to bypass the heart and lungs and return oxygenated blood into the arterial system from the ECMO machine. Oxygenators are used to replace the role of lungs by removing CO2 and oxygenating venous blood prior to being returned to the heart or arterial system. Pumps are used to manage the drainage of venous blood, flow rate through the oxygenator, and flow rate for returning oxygenated blood.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ECMO market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ECMO market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ECMO market.
• Competitive dynamics insights and trends provided ECMO market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Getinge USA Inc (MAQUET), Terumo Corp, ALung Technologies, LivaNova plc (Sorin Group), Medtronic plc, MicroPort Scientific Corporation, Eurosets Srl, OriGen Biomedical Inc, Fresenius Medical Care Group (Xenios AG), and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ECMO marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ECMO marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on ECMO market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving ECMO market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ECMO market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ECMO market from 2015-2030.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.